Literature DB >> 23248255

BRAF mutations in Erdheim-Chester disease.

Jean-François Emile, Frédéric Charlotte, Zahir Amoura, Julien Haroche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23248255     DOI： 10.1200/JCO.2012.46.9676

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

1.  Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease.

Authors:  Jean-François Emile; Eli L Diamond; Zofia Hélias-Rodzewicz; Fleur Cohen-Aubart; Frédéric Charlotte; David M Hyman; Eunhee Kim; Raajit Rampal; Minal Patel; Chezi Ganzel; Shlomzion Aumann; Gladwys Faucher; Catherine Le Gall; Karen Leroy; Magali Colombat; Jean-Emmanuel Kahn; Salim Trad; Philippe Nizard; Jean Donadieu; Valérie Taly; Zahir Amoura; Omar Abdel-Wahab; Julien Haroche
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

2.  Writing guidelines without a net: ECD.

Authors:  Oussama Abla; Robert Arceci
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

3.  Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation.

Authors:  Moozhan Nikpanah; Lauren Kim; S Mojdeh Mirmomen; Rolf Symons; Ioannis Papageorgiou; William A Gahl; Kevin O'Brien; Juvianee I Estrada-Veras; Ashkan A Malayeri
Journal:  Eur Radiol       Date:  2018-03-19       Impact factor: 5.315

Review 4.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Fleur Cohen-Aubart; Baptiste Hervier; Frédéric Charlotte; Jean-François Emile; Zahir Amoura
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

5.  Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.

Authors:  Ankush Bhatia; Vaios Hatzoglou; Gary Ulaner; Raajit Rampal; David M Hyman; Omar Abdel-Wahab; Benjamin H Durham; Ahmet Dogan; Neval Ozkaya; Mariko Yabe; Kseniya Petrova-Drus; Katherine S Panageas; Anne Reiner; Marc Rosenblum; Eli L Diamond
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

6.  Rare form of erdheim-chester disease presenting with isolated central skeletal lesions treated with a combination of alfa-interferon and zoledronic Acid.

Authors:  E N Bulycheva; V V Baykov; M I Zaraĭskiĭ; G N Salogub
Journal:  Case Rep Hematol       Date:  2015-04-08

Review 7.  Oncogene-induced senescence as a new mechanism of disease: the paradigm of erdheim-chester disease.

Authors:  Giulio Cavalli; Riccardo Biavasco; Bruno Borgiani; Lorenzo Dagna
Journal:  Front Immunol       Date:  2014-06-13       Impact factor: 7.561

8.  Efficacy of MEK inhibition in patients with histiocytic neoplasms.

Authors:  Eli L Diamond; Benjamin H Durham; Gary A Ulaner; Esther Drill; Justin Buthorn; Michelle Ki; Lillian Bitner; Hana Cho; Robert J Young; Jasmine H Francis; Raajit Rampal; Mario Lacouture; Lynn A Brody; Neval Ozkaya; Ahmet Dogan; Neal Rosen; Alexia Iasonos; Omar Abdel-Wahab; David M Hyman
Journal:  Nature       Date:  2019-03-13       Impact factor: 49.962

9.  Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates.

Authors:  Huanyu Ding; Yang Li; Caishun Ruan; Yuan Gao; Hehua Wang; Xiangsong Zhang; Zhihong Liao
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-09-03

10.  Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease.

Authors:  Jaume Monmany; Esther Granell; Laura López; Pere Domingo
Journal:  BMJ Case Rep       Date:  2018-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.